releasing hormone agonist therapy

Known as: Releasing Factor Agonist Therapy, agonist, releasing hormone therapy, therapy, releasing hormone agonist 
The use of releasing hormone agonists to bind to specific receptors and ultimately downregulate the activity of its specific hormone.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2017
01219922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Leiomyomatosis peritonealis disseminata is a rare disease characterized by pelvic smooth-muscle nodules of various sizes. It is… (More)
Is this relevant?
Review
2007
Review
2007
PURPOSE To investigate whether failure to suppress the prostate-specific antigen (PSA) level to <or=1 ng/mL after >or=2 months of… (More)
Is this relevant?
2006
2006
OBJECTIVES It was the aim of this study to analyze the failure rates in achieving or maintaining castrate levels of serum… (More)
Is this relevant?
2006
2006
Follicle-stimulating hormone has been shown to be a mitogen in preclinical models of androgen-independent prostate cancer and… (More)
Is this relevant?
2004
2004
The hypothesis that follicle-stimulating hormone (FSH) signaling contributes to the progression of androgen-independent prostate… (More)
Is this relevant?
1993
1993
Three pre-menopausal women with uterine myomas were treated with leuprolide acetate depot and experienced profuse vaginal… (More)
Is this relevant?
1992
1992
A 39-year-old woman with an enlarging myomatous uterus underwent a three-month course of luteinizing hormone releasing hormone… (More)
Is this relevant?